| |
GroupA: Isolated Colonic Peritoneal Metastases |
GroupB: Colonic Peritoneal and Liver Metastases |
Pvalue |
| Total |
42 |
36 |
— |
| Follow-up(median) |
21.5 |
21.9 |
— |
| Age(years) |
|
|
|
| Mean(s.d.) |
59.4(14.3) |
60.3(12.6) |
0.54 |
| Sex |
|
|
|
| Male |
19(44.2) |
15(41.6) |
0.75 |
| Female |
23(54.8) |
21(58.4) |
| PCI |
|
|
|
| Mean(s.d.) |
12.7(9.9) |
7.0(5.1) |
<0.001 |
| Completenessofcytoreduction |
| CC0 |
39(92.8) |
35(97.2) |
0.58 |
| CC1 |
2(4.8) |
1(2.8) |
| CC2 |
1(2.4) |
0 |
| HIPEC |
| Yes |
36(85.7) |
18(50) |
0.001 |
| No |
6(14.3) |
18(50) |
| TumourGrade |
| Well |
0 |
2(5.5) |
0.11 |
| Moderate |
27(64.3) |
27(75) |
| Poor |
15(35.7) |
7(19.5) |
| MucinousHistology |
| Yes |
19(45.2) |
8(22.2) |
0.03 |
| No |
23(54.8) |
28(77.8) |
| LymphNodeStatus |
| Positive |
29(69) |
16(44.4) |
0.76 |
| Negative |
13(31) |
20(55.6) |
| Pre-OperativeChemotherapy |
| Yes |
17(40.9) |
33(91.7) |
<0.001 |
| No |
25(59.1) |
3(8.3) |
| Post-OperativeChemotherapy |
| Yes |
34(81) |
33(91.7) |
0.18 |
| No |
8(19) |
3(8.3) |
| DurationofProcedure(hours) |
| Mean(s.d.) |
8.0(3.1) |
6.1(2.3) |
0.23 |
| DurationofICUStay(days) |
| Mean(s.d.) |
3.0(3.1) |
2.4(2.7) |
0.28 |
| DurationofHospitalStay(days) |
| Mean |
23.7(13.9) |
21.8(11.6) |
0.66 |
| BloodTransfusion(units) |
| Mean(s.d.) |
4.0(4.4) |
2.4(2.5) |
0.09 |
| MajorComplications |
| Yes |
13(31) |
14(38.9) |
0.46 |
| No |
29(69) |
22(61.1) |
| Survival |
| Overall,median(months) |
45.5 |
24.4 |
0.03 |
| Disease-free,median(months) |
17.7 |
8.5 |
0.002 |
| 1-yearoverall(%) |
95 |
74 |
— |
| 3-yearoverall(%) |
62 |
33 |
— |
| 5-yearoverall(%) |
31 |
18 |
— |
| Recurrence |
| Yes |
30(71.4) |
31(86.1) |
0.12 |
| No |
12(28.6) |
5(13.9) |